Correlation Between Structure Therapeutics and Dice Molecules

Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Dice Molecules at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Dice Molecules into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Structure Therapeutics American and Dice Molecules Holdings, you can compare the effects of market volatilities on Structure Therapeutics and Dice Molecules and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Dice Molecules. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Dice Molecules.

Diversification Opportunities for Structure Therapeutics and Dice Molecules

0.0

Correlation Coefficient

Structure Therapeutics  Dice Molecules

Pay attention - limited upside

The 3 months correlation between Structure and Dice is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Dice Molecules Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dice Molecules Holdings and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Dice Molecules. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dice Molecules Holdings has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Dice Molecules go up and down completely randomly.

Pair Corralation between Structure Therapeutics and Dice Molecules

If you would invest (100.00) in Dice Molecules Holdings on December 30, 2024 and sell it today you would earn a total of  100.00  from holding Dice Molecules Holdings or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Structure Therapeutics America  vs.  Dice Molecules Holdings

Structure Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Dice Molecules Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Structure Therapeutics and Dice Molecules

The main advantage of trading using opposite Structure Therapeutics and Dice Molecules positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Dice Molecules can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will offset losses from the drop in Dice Molecules' long position.

The idea behind Structure Therapeutics American and Dice Molecules Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.